You should explain your last paragraph for new people Dr Brad! Lol!
CR formulation is great. Better compliance for clinical trials & marketing for drug once registered & ease of use. That's important. Was very happy with ANN.
Ann: DMX-200 tablet manufacture and human study timeline, page-3
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $217.5M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 38.0¢ | $275.3K | 716.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 72085 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 38980 | 4 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |